Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (9): 528-535.
DOI: 10.19803/j.1672-8629.2019.09.03

Previous Articles     Next Articles

Research on the Status Quo of the Regulation of Compound Tramadol

SUN Zhenhui1, SUN Jun2, WANG Jiayu2, YU Dandan2, WANG Ling3, YU Zheng1,*   

  1. 1 China Pharmaceutical University, Jiangsu Nanjing 211198, China;
    2 Center for ADR Monitoring of Jiangsu, Jiangsu Nanjing 210002, China;
    3 National Center for ADR Monitoring, Beijing 100022, China
  • Received:2019-04-25 Revised:2019-10-21 Online:2019-09-20 Published:2019-10-21

Abstract: Objective To summarize supervision experiences in various countries with an eye to providing ideas for China on basis of introducing current status of compound tramadol abuse worldwide. Methods To Summarize and compare the abuse status, supervision situations and measures, etc. in various countries through literature review. Results In comparison with foreign experiences, China was confronted with the following problems: differentiation of control level for tramadol and its compound preparations, lack of comprehensive surveillance on prescription, inadequate description of addiction in the package insert, limited knowledge of drug abuse of healthcare professionals. Conclusion China should make efforts to uniform control level for all tramadol containing preparations, set up medication tracking system, revise the package insert to emphasis the risk of addiction and strengthen awareness and training on risks of drug abuse.

Key words: compound tramadol, addiction, drug abuse, control hierarchy, international supervision

CLC Number: